Skip to content

SAVE THE DATE! Join us for the Nebraska Infectious Diseases Conference on August 28, 2026.  More details to follow!

Blogs

Antibiotic Awareness

Early Oral Therapy for Staphylococcus aureus Bloodstream Infections

Click this link for Early Oral Therapy for Staphylococcus aureus Bloodstream Infections New Guidance: Early Oral Therapy for Staphylococcus aureus…

arrow_forward

Nebraska NHSN Antibiotic Use and Resistance Reporting

Nebraska NHSN Antibiotic Use and Resistance Reporting: Implementation Progress and Updates The CDC’s National Healthcare Safety Network Antimicrobial Use and…

arrow_forward

NHSN Antimicrobial Use and Resistance (AUR) Module Reporting – CMS required by 2024!

NHSN Antimicrobial Use and Resistance (AUR) Module Reporting – CMS required by 2024! Antibiotic Awareness Week 2022 Antimicrobial resistance rates…

arrow_forward

CDC Updates Core Elements of Hospital Antibiotic Stewardship Programs

In November 2019, CDC revised the Core Elements of Hospital Antibiotic Stewardship Programs to provide an updated framework to assist…

arrow_forward

Joint Commission and CMS Conditions of Participation Updates for Antimicrobial Stewardship Programs in Hospitals and Critical Access Hospitals

Joint Commission and CMS Conditions of Participation Updates for Antimicrobial Stewardship Programs in Hospitals and Critical Access Hospitals Antibiotic Awareness…

arrow_forward

Antimicrobial Stewardship Program Guidance – Acute Care Hospitals

The Road to Reporting: National Healthcare Safety Network Antibiotic Use and Resistance Module

Sessions 3-5 – Demos from Multiple AUR Submission Vendors Objectives:  View demonstrations from various CDC validated software vendors. The Nebraska…

arrow_forward

Joint Commission and CMS Conditions of Participation Updates for Antimicrobial Stewardship Programs in Hospitals and Critical Access Hospitals

Joint Commission and CMS Conditions of Participation Updates for Antimicrobial Stewardship Programs in Hospitals and Critical Access Hospitals Antibiotic Awareness…

arrow_forward

NHSN Antimicrobial Use and Resistance (AUR) Module Reporting – CMS required by 2024!

NHSN Antimicrobial Use and Resistance (AUR) Module Reporting – CMS required by 2024! Antibiotic Awareness Week 2022 Antimicrobial resistance rates…

arrow_forward

Antibiotic Use Tracking Resources and Guidance

Tracking antibiotic use is a core antimicrobial stewardship activity that provides the necessary data to guide stewardship interventions and improve…

arrow_forward

CDC Updates Core Elements of Hospital Antibiotic Stewardship Programs

In November 2019, CDC revised the Core Elements of Hospital Antibiotic Stewardship Programs to provide an updated framework to assist…

arrow_forward

CMS Finalized New Conditions of Participation for Hospitals and Critical Access Hospitals

On September 30th, 2019, the Center for Medicare and Medicaid Services finalized a new set of Conditions of Participation for…

arrow_forward

Five New Tools for the Month of May

A number of new tools have been posted during the month of May.  A brief description of each tool is…

arrow_forward

How Nebraska ASAP Is Making Everyone Antibiotic Aware

Written by Dr. M. Salman Ashraf, Nebraska ASAP Co-Medical Director Antibiotic Resistance is one of the most urgent threats to…

arrow_forward

Establishing Antimicrobial Stewardship Programs in Small and Critical Access Hospitals

In 2014, the CDC published The Core Elements of Hospital Antibiotic Stewardship Programs to assist acute care facilities implement antimicrobial…

arrow_forward

Antimicrobial Stewardship Program Guidance – Long-Term Care

Antibiotic Use Tracking Resources and Guidance

Tracking antibiotic use is a core antimicrobial stewardship activity that provides the necessary data to guide stewardship interventions and improve…

arrow_forward

Nebraska ASAP Efforts to Promote Antimicrobial Stewardship Activities in Long-Term Care Facilities Across the State

Antibiotic use is common in long-term care facilities (LTCF) with 70% of residents receiving at least one course of systemic…

arrow_forward

AMDA Publishes ASP Policy Template for Post-Acute and Long-Term Care Settings

Antibiotic use is common in long-term care facility (LTCF) with 70% of residents receiving at least one course of systemic…

arrow_forward

Antimicrobial Stewardship Program Guidance – Outpatient Clinics

Outpatient Antibiotic Stewardship Assessment Tool

Due to the increasing threat of antibiotic resistance, antibiotic stewardship is a vital function within healthcare systems to ensure that…

arrow_forward

Implementing Antimicrobial Stewardship Efforts Across Different Healthcare Settings

 The CDC recommends implementation of antimicrobial stewardship efforts across various healthcare settings (acute, post-acute and long-term, and ambulatory care) as…

arrow_forward

New CDC Antibiotic Stewardship Training Targets Outpatient Settings

This week, CDC launched the second installment of the free web-based antibiotic stewardship training.  The first installment, which include 3…

arrow_forward

Opportunities to Improve Fluoroquinolone Use in Adults Exist in Ambulatory Care Settings

Systemic fluoroquinolones* (FQ) currently in use include ciprofloxacin, levofloxacin, moxifloxacin, gemifloxacin, delafloxacin and ofloxacin.   These agents have a number of…

arrow_forward

Antimicrobial Stewardship in the Outpatient Setting

Antimicrobial stewardship is not only about inpatient antimicrobial prescribing.  Inappropriate outpatient antibiotic prescribing has contributed to the development of resistant…

arrow_forward

Antimicrobial Drug Information

Infectious Diseases Society of America Community – Acquired Pneumonia Clinical Pathway Overview

In 2019, the Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) released a clinical practice guideline for…

arrow_forward

Summary of 8 Antibiotic Myths for Infectious Disease Clinicians

Summary of 8 Antibiotic Myths for Infectious Disease Clinicians By Savona Bateman, PharmD candidate 2024   Antibiotic usage frequently has…

arrow_forward

Penicillin Allergy Risk Low? Challenge with PO!

More evidence supports that proceeding directly to an oral penicillin challenge in patients who are low risk for penicillin allergy.…

arrow_forward

#PharmtoExamTable: Cefepime Neurotoxicity

This #PharmToExamTable post exploring the pathophysiology and approach to cefepime neurotoxicity was authored by Xiaotong Zhang and Kaycee Bartels, 2023 PharmD candidates at…

arrow_forward

Nebraska DHHS HAN | Update: COVID-19 therapeutics updates and antibiotic shortages

On November 7, 2022, Ne DHHS released a HAN regarding COVID-19 therapeutics updates & shortages of oseltamivir, amoxicillin, & amoxicillin-clavulanate.…

arrow_forward

National shortage of Tamiflu (oseltamivir)

Pharmacies are experiencing a national shortage of oseltamivir suspension and capsules and very few doses remain available. Oseltamivir can be…

arrow_forward

CDC MMWR Early Release | Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19

On November 22, 2022 the CDC issued an early release of an MMWR article. The article,  ‘Paxlovid Associated with Decreased…

arrow_forward

Influential Papers in Antimicrobial Stewardship 2022

Influential Papers in Antimicrobial Stewardship 2022 Antibiotic Awareness Week 2022  This year for Antibiotic Awareness Week, we encourage practitioners to…

arrow_forward

Addressing Reported Penicillin Allergy – A 2022 Practice Parameter Update

Addressing Reported Penicillin Allergy – A 2022 Practice Parameter Update Antibiotic Awareness Week 2022 Patient reported antibiotic allergies present clinicians…

arrow_forward

Guidance for the Use of Proton Pump Inhibitors

Proton pump inhibitors (PPI’s) are one of the most commonly used classes of drugs, due in part to their presumed…

arrow_forward

Does Piperacillin-Tazobactam Measure Up to Meropenem for ESBL Bloodstream Infections?

Extended-spectrum β-lactamase (ESBL)-producing Gram negative bacilli (GNB) have been classified by the CDC as a serious threat in its report…

arrow_forward

Management of Common Infections in Long-Term Care

During the Nebraska Antimicrobial Stewardship Summit on June 1st, 2018, Dr. Christopher Crnich from the University of Wisconsin at Madison…

arrow_forward

Antimicrobial Stewardship and Rapid Diagnostic Testing in Acute Care

Implementation of effective antimicrobial stewardship programs (ASP) typically requires a multipronged approach.  The Infectious Diseases Society of America (IDSA) and…

arrow_forward

IDSA and SHEA Update Clostridium difficile Infection Clinical Practice Guidelines

Clostridium difficile* infections (CDI) are associated with significant morbidity and mortality in the United States.  Based on data from 2006…

arrow_forward

FDA Issues New Safety Communication on Clarithromycin Use in Patients with Heart Disease

On February 22nd, the Food & Drug Administration (FDA) issued a new drug safety communication to health care providers regarding…

arrow_forward

Evidence-Based Implementation Guide to Reduce Treatment of Asymptomatic Bacteriuria

Asymptomatic bacteriuria (ASB) is defined as “isolation of pre-specified quantitative count of bacteria in an appropriately collected urine specimen obtained…

arrow_forward

Antibiotic-Associated Adverse Drug Events in Hospitalized Patients

Antibiotics are life-saving medications that make modern medical care such as surgical procedures, organ transplantations, cancer chemotherapy possible.  Unfortunately, their…

arrow_forward

Blue Cross Blue Shield Report Shows Drop in Antibiotic Prescription Fill Rates

A report published by the Blue Cross Blue Shield Association, in partnership with HealthCore and Blue Health Intelligence, indicates a…

arrow_forward

Cephalexin With or Without TMP-SMX Showed Similar Efficacy for Uncomplicated Cellulitis

The Infectious Diseases Society of America recommends use of antimicrobial agent active only against streptococci (e.g., cephalexin) for management of…

arrow_forward

Pharmacist-Driven Intervention Improves Care of Patients with S aureus Bacteremia

Staphylococcus aureus bacteremia (SAB) is associated significant morbidity and mortality.  Previous studies have shown Infectious Diseases (ID) consultation for patients with SAB optimizes care and…

arrow_forward

Subscribe to Nebraska ASAP Communications

This field is for validation purposes and should be left unchanged.
Name
Scroll To Top expand_less

Sign up for Email Updates

Please provide your details below to reach out to our ASAP team on any questions about Antimicrobial Stewardship.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Address*
Name*